The role of Tomosyn-2 in insulin secretion and glucose tolerance

Tomosyn-2在胰岛素分泌和葡萄糖耐量中的作用

基本信息

  • 批准号:
    9913532
  • 负责人:
  • 金额:
    $ 37.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-05 至 2024-01-31
  • 项目状态:
    已结题

项目摘要

Type 2 diabetes (T2D) has reached epidemic proportions, with ~9.4% of the US adult population being diabetic, and another 84.1 million have pre-diabetes. It is currently acknowledged that both insulin resistance and b-cell dysfunction are early and essential events in the development of T2D. The formation of the SNARE (Soluble NSF Attachment Protein Receptor) complex is rate limiting for insulin secretion. Our understanding of factors that regulate the formation of the SNARE complex and how they contribute to reduced insulin secretion from b- cells in impaired glucose tolerance is lacking. To this end, by using forward genetics approach, we have identified Tomosyn-2, which is an endogenous inhibitor of insulin secretion and functions by binding to syntaxin. Syntaxin is a key component of the SNARE complex that modulates the fusion of the insulin granules to the plasma membrane for insulin secretion from b-cells. We have discovered that a gain-of-function mutation in the Tomosyn-2 gene led to an increase in islet Tomosyn-2 protein abundance and formation of hypoinsulinemic/ hyperglycemic phenotypes in mice. Increased abundance and/or the functional activity of Tomosyn-2 causes reduction in insulin secretion from human and mouse islets. Thus, the long-term goal is to understand how Tomosyn-2 function in b-cells can be manipulated to improve insulin secretion in impaired glucose tolerance for the treatment and prevention of prediabetes and T2D. The objective of this application is to determine how Tomosyn-2 inhibits insulin secretion from b-cells in the pathophysiology, physiology, and at the molecular level, and how its inhibitory function in b-cells is regulated. Our data show that the improved glucose tolerance in Tomosyn-2-null mice is a direct result of enhanced insulin secretion from pancreatic islets. Further, reduced insulin secretion is observed in islets of mice on a high-fat diet that have elevated Tomosyn-2 protein levels. We have identified phosphorylation sites in response to major b-cell signaling pathways that modulate Tomosyn-2 inhibitory function. Also, E3-ubiquitin ligase, Hrd1 and an insulin granule protein, Syt9 bind and regulate the protein abundance of Tomosyn-2. Our hypothesis is that Tomosyn-2 is a key protein in the exocytotic machinery that regulates SNARE complex-mediated insulin secretion in response to nutritional and genetic cues, and that specific post-translational modifications of Tomosyn-2 increase insulin secretion. To test this hypothesis, we propose three aims: 1) determine the sub-cellular mechanisms by which Tomosyn-2 inhibits insulin secretion, 2) determine Tomosyn-2 phosphorylation regulates its activity on downstream insulin secretion, and 3) determine the role of the Tomosyn-2-binding proteins, Syt9 and Hrd1, in regulating insulin secretion. Outcomes from this project will provide novel information on how b-cells prevent inappropriate insulin secretion, identify the molecular target for the early phase insulin secretion, and insights into the loss in fusion competency of insulin granules during impaired glucose tolerance. Our results will provide fundamental new knowledge of the nutritional and hormonal regulation of the SNARE complex, identifying steps that could be modulated therapeutically in T2D.
2型糖尿病(T2 D)已达到流行比例,约9.4%的美国成年人口患有糖尿病, 另有8410万人患有糖尿病前期。目前认为,胰岛素抵抗和B细胞 功能障碍是T2 D发展中的早期和基本事件。陷阱的形成(可溶性) NSF附着蛋白受体)复合物是胰岛素分泌的限速剂。我们对因素的理解 调节SNARE复合物的形成,以及它们如何有助于减少B- 葡萄糖耐量受损的细胞缺乏。为此,通过使用正向遗传学方法,我们已经确定, Tomosyn-2是胰岛素分泌的内源性抑制剂,通过与突触融合蛋白结合发挥作用。Syntaxin 是调节胰岛素颗粒与血浆融合的SNARE复合物的关键成分 B细胞分泌胰岛素的膜。我们发现基因组中的功能获得性突变 Tomosyn-2基因导致胰岛Tomosyn-2蛋白丰度增加,并形成低胰岛素血症。 高血糖表型。Tomosyn-2的丰度和/或功能活性的增加导致 减少人和小鼠胰岛的胰岛素分泌。因此,长期目标是了解如何 Tomosyn-2在B细胞中的功能可以被操纵以改善葡萄糖耐量受损的胰岛素分泌, 糖尿病前期和T2 D的治疗和预防。本申请的目的是确定如何 Tomosyn-2在病理生理学、生理学和分子水平上抑制b细胞的胰岛素分泌, 以及它在B细胞中的抑制功能是如何被调节的。我们的数据表明, Tomosyn-2缺失小鼠是胰岛胰岛素分泌增强的直接结果。此外,减少 在Tomosyn-2蛋白水平升高的高脂肪饮食小鼠的胰岛中观察到胰岛素分泌。我们 已经鉴定了响应于调节Tomosyn-2的主要b细胞信号通路的磷酸化位点 抑制功能此外,E3-泛素连接酶Hrd 1和胰岛素颗粒蛋白Syt 9结合并调节胰岛素的分泌。 Tomosyn-2的蛋白丰度。我们的假设是Tomosyn-2是胞吐机制中的关键蛋白 调节SNARE复合物介导的胰岛素分泌以响应营养和遗传线索, Tomosyn-2的特异性翻译后修饰增加胰岛素分泌。为了验证这个假设,我们 提出三个目标:1)确定Tomosyn-2抑制胰岛素分泌的亚细胞机制,2) 确定Tomosyn-2磷酸化调节其对下游胰岛素分泌的活性,以及3)确定 Tomosyn-2结合蛋白Syt 9和Hrd 1在调节胰岛素分泌中的作用。由此产生的结果 该项目将提供关于b细胞如何防止胰岛素分泌不当的新信息, 早期胰岛素分泌的靶点,以及对胰岛素颗粒融合能力丧失的认识 葡萄糖耐量受损的时候。我们的研究结果将提供有关营养和 SNARE复合物的激素调节,确定可以在T2 D中进行治疗调节的步骤。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sushant Bhatnagar其他文献

Sushant Bhatnagar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sushant Bhatnagar', 18)}}的其他基金

Investigating the Effects of ADGRB3 Signaling on Incretin-Mediated Insulin Secretion from Pancreatic Beta-Cells
研究 ADGRB3 信号传导对肠促胰素介导的胰腺 β 细胞胰岛素分泌的影响
  • 批准号:
    10666206
  • 财政年份:
    2023
  • 资助金额:
    $ 37.13万
  • 项目类别:
Identifying secreted protein networks affecting human pancreatic islet function in type 2 diabetes using public omic databases
使用公共组学数据库识别影响 2 型糖尿病患者胰岛功能的分泌蛋白网络
  • 批准号:
    10372456
  • 财政年份:
    2021
  • 资助金额:
    $ 37.13万
  • 项目类别:
Identifying secreted protein networks affecting human pancreatic islet function in type 2 diabetes using public omic databases
使用公共组学数据库识别影响 2 型糖尿病患者胰岛功能的分泌蛋白网络
  • 批准号:
    10488268
  • 财政年份:
    2021
  • 资助金额:
    $ 37.13万
  • 项目类别:
The role of Tomosyn-2 in insulin secretion and glucose tolerance
Tomosyn-2在胰岛素分泌和葡萄糖耐量中的作用
  • 批准号:
    10348695
  • 财政年份:
    2019
  • 资助金额:
    $ 37.13万
  • 项目类别:
The role of Tomosyn-2 in insulin secretion and glucose tolerance
Tomosyn-2在胰岛素分泌和葡萄糖耐量中的作用
  • 批准号:
    10549803
  • 财政年份:
    2019
  • 资助金额:
    $ 37.13万
  • 项目类别:
The role of Tomosyn-2 in insulin secretion and glucose tolerance
Tomosyn-2在胰岛素分泌和葡萄糖耐量中的作用
  • 批准号:
    10090593
  • 财政年份:
    2019
  • 资助金额:
    $ 37.13万
  • 项目类别:
THE ROLE OF TOMOSYN-2 IN INSULIN SECRETION
TomoSYN-2 在胰岛素分泌中的作用
  • 批准号:
    9411112
  • 财政年份:
    2016
  • 资助金额:
    $ 37.13万
  • 项目类别:
The role of tomosyn-2 in insulin secretion
Tomosyn-2在胰岛素分泌中的作用
  • 批准号:
    8916088
  • 财政年份:
    2014
  • 资助金额:
    $ 37.13万
  • 项目类别:
The role of tomosyn-2 in insulin secretion
Tomosyn-2在胰岛素分泌中的作用
  • 批准号:
    8766798
  • 财政年份:
    2014
  • 资助金额:
    $ 37.13万
  • 项目类别:

相似海外基金

Late-Stage Functionalisation of Cyclic Guanosine Monophosphate - Adenosine Monophosphate
环单磷酸鸟苷-单磷酸腺苷的后期功能化
  • 批准号:
    2751533
  • 财政年份:
    2022
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Studentship
The Role of Chronic Pharmacological Adenosine Monophosphate-Activated Protein Kinase Activation at the Neuromuscular Junction
慢性药理学单磷酸腺苷激活蛋白激酶激活在神经肌肉接头处的作用
  • 批准号:
    575833-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Targeting adenosine monophosphate activated protein kinase (AMPK) to reduce cocaine relapse
靶向单磷酸腺苷激活蛋白激酶 (AMPK) 减少可卡因复吸
  • 批准号:
    10593045
  • 财政年份:
    2022
  • 资助金额:
    $ 37.13万
  • 项目类别:
Targeting adenosine monophosphate activated protein kinase (AMPK) to reduce cocaine relapse
靶向单磷酸腺苷激活蛋白激酶 (AMPK) 减少可卡因复吸
  • 批准号:
    10303255
  • 财政年份:
    2022
  • 资助金额:
    $ 37.13万
  • 项目类别:
The regulation of electrical coupling between neuroendocrine cells by cyclic adenosine monophosphate and protein kinase A
环磷酸腺苷与蛋白激酶A对神经内分泌细胞电耦合的调节
  • 批准号:
    565217-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Dissecting the Molecular Mechanisms of the Histone Acetyltransferase/Cyclic Adenosine Monophosphate Binding Protein Interactome Using Protein-Observed Fluorine NMR
使用蛋白质观察的氟 NMR 剖析组蛋白乙酰转移酶/环单磷酸腺苷结合蛋白相互作用组的分子机制
  • 批准号:
    1904071
  • 财政年份:
    2019
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Standard Grant
Osmotic stress regulation and the role of cyclic di-adenosine monophosphate (c-di-AMP) in Staphylococcus aureus
金黄色葡萄球菌的渗透应激调节和环二腺苷单磷酸 (c-di-AMP) 的作用
  • 批准号:
    318765828
  • 财政年份:
    2016
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Research Fellowships
Novel mechanisms controlling signaling by adenosine monophosphate-activated protein kinase, central regulator of energy homeostasis
通过单磷酸腺苷激活蛋白激酶控制信号传导的新机制,能量稳态的中央调节器
  • 批准号:
    FT130100988
  • 财政年份:
    2014
  • 资助金额:
    $ 37.13万
  • 项目类别:
    ARC Future Fellowships
The roles of cyclic adenosine monophosphate (cAMP) in suppressive functions of regulatory T cells
环磷酸腺苷 (cAMP) 在调节性 T 细胞抑制功能中的作用
  • 批准号:
    25893115
  • 财政年份:
    2013
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Molecular mechanisms of cyclic Adenosine Monophosphate (AMP) induced apoptosis
环磷酸腺苷(AMP)诱导细胞凋亡的分子机制
  • 批准号:
    DP110100417
  • 财政年份:
    2011
  • 资助金额:
    $ 37.13万
  • 项目类别:
    Discovery Projects
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了